Federal regulators are proposing to remove another artificial dye from the U.S. food supply — Orange B, a synthetic color ...
The FDA’s proposed Rare Disease Evidence Principles review process is a starting point for getting rare disease therapies ...
The agency says it’s open to offering speedy approval pathways for new pain medications that can fight the ongoing opioid ...
The U.S. Food and Drug Administration has approved the 2025-26 vaccine for use, but for a narrower pool of Americans. The ...
Direct-to-consumer drug ads have long blurred the line between patient empowerment and corporate persuasion, but the FDA is ...
The Food and Drug Administration released a final rule Sept. 18 that rescinds one from 2024 that applied medical device rules ...
Regulation of lab developed tests returns to its status before the agency attempted to expand its jurisdiction and industry ...
In today's Morning Rounds newsletter, NIH is finally spending down its coffers, FDA eyes tighter regulations on chatbots for ...
The FDA is launching a pilot program to ease requirements for nicotine pouch manufacturers, showing a potential policy shift ...
Manufacturers shouldn't try to address this guidance without specific feedback and support from cybersecurity experts.c ...
A complex state vs. federal regulatory scheme allows drug compounders to advertise drugs without disclosing risks like a ...
2don MSN
Exclusive: FDA nicotine pouch pilot to ease manufacturers' research burden, transcript shows
The U.S. Food and Drug Administration will ease requirements on nicotine pouch manufacturers under a new pilot program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback